Correspondence| Volume 28, ISSUE 12, P1072-1073, December 15, 1990

Drug versus behavioral treatment of obsessive-compulsive disorder

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Katz R.J.
        • De Veaugh-Geiss J.
        • Landau P.
        Clomipramine in obsessive-compulsive disorder.
        Biol Psychiatry. 1990; 28: 401-414
        • Marks I.M.
        • de Albuquerque A.
        • Cottraux J.
        • et al.
        The “efficacy” of alprazolam in panic disorder and agoraphobia: A critique of recent reports (Letter).
        Arch Gen Psychiatry. 1989; 46: 668-669
        • Marks I.M.
        • O'Sullivan G.
        Drugs and psychological treatments for agoraphobia/panic and OCD: A review.
        Br J Psychiatry. 1988; 153: 650-658
        • Marks I.M.
        • Stern C.S.
        • Mawson D.
        • et al.
        Clomipramine and exposure for obsessive-compulsive rituals.
        Br J Psychiatry. 1980; 136: 1-25
        • Marks I.M.
        • Lelliott P.
        • Basoglu M.
        • et al.
        Clomipramine, self-exposure, and therapist-aided exposure for obsessive-compulsive rituals.
        Br J Psychiatry. 1988; 152: 522-534
        • Monteiro W.O.
        • Noshirvani H.F.
        • Marks I.M.
        • Lelliott P.T.
        Anorgasmia from clomipramia in OCD: A controlled trial.
        Br J Psychiatry. 1987; 151: 107-112
        • O'Sullivan G.
        • Marks I.M.
        Long-term outcome of phobic and OCD after exposure: A review.
        in: Handbook of Anxiety. Elsevier, Amsterdam1990
        • Oxtoby A.
        • Jones A.
        • Robinson M.
        Is your “double-blind” design truly double-blind?.
        Br J Psychiatry. 1989; 155: 700-701
        • Pato M.T.
        • Zohar-Kadouch R.
        • Zohar J.
        • Murphy D.L.
        Return of symptoms after discontinuation of clomipramine in OCD.
        Am J Psychiatry. 1988; 145: 1521-1525